Fig. 2 | Nature Communications

Fig. 2

From: Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence

Fig. 2

Extended release of drugs from localized iGel can reduce systemic toxicity. a Fluorescence imaging depicting the retention of IR dye-labeled MNDVs after treatment. b Serum levels of IL-6 and c percentage of body weight change following subcutaneous administration of different treatment groups. Data are presented as the means ± S.D. (n = 4). P-values were analyzed by one-way ANOVA and Tukey’s test (serum IL-6 data at 3 h and body weight data at day 1). The results are representative of one of two independent experiments. Source data are provided as a Source Data file

Back to article page